WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 15-July-2017 (data as of 11-July-2017)
Next overall update Fall-2017
EPI mother and child logo         
Select a country

Development status: Developed Economy GNI / capita (US$): 12'6901 Infant (under 12 months) mortality rate: 42
GDP / capita (US$): 21'8801 Child (under 5 years) mortality rate: 42

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 4'213  4'236  4'258  4'278  4'297  4'428  4'776  4'598 
Births 39  39  40  41  42  45  54  66 
Surviving infants 39  39  40  41  42  45  53  65 
Pop. less than 5 years 196  205  211  219  226  243  293  324 
Pop. less than 15 years 619  628  635  646  659  767  945  968 
Female 15-49 years 928  939  949  958  967  1'085  1'163  1'168 

Number of reported cases

(Click for retrospective incidence data for Croatia)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  206  119 
Mumps
ChartChart
  33  29  35  95  152 
Pertussis
ChartChart
  122  57  108  61  196  304 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
  18 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Croatia)
Vaccine year result method % card seen                                                
BCG          99  98  98  99  99  98 
DTP1          98 
DTP3          93  94  95  96  96  93 
DTP4          87  90  92 
IPV1         
HepB_BD          98  96 
HepB3          93  94  95  96  98 
Hib3          93  94  95  96 
JapEnc         
MCV1          90  93  94  94  95  93 
MCV2          96  96  97  97  97 
MenA         
PCV1         
PCV2         
PCV3         
Pol3          93  94  95  96  96  94 
Rota1         
RotaC         
RCV1          90  93  94  94  95 
TT2plus          97 
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Croatia)
BCG
ChartChart
  99  98  98  99  99  98 
DTP1
ChartChart
  98  98  98  98  98  95 
DTP3
ChartChart
  93  94  95  96  96  93 
HepB3
ChartChart
  93  94  95  96  98 
HepB_BD
ChartChart
  98  98  96 
Hib3
ChartChart
  93  94  95  96  96 
MCV1
ChartChart
  90  93  94  94  95  93 
MCV2
ChartChart
  96  96  97  97  97 
PCV3
 
Pol3
ChartChart
  93  94  95  96  96  94 
RCV1
ChartChart
  90  93  94  94  95  93 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 21  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 90
From 80 to 89% 10
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTaP 5 years; Yes
DTaPHibHepIPV 2, 4, 6 months; 1 year; Yes
HepB_Pediatric 13 years (x3); Yes
HPV 14, 14, 15 years; Yes
Influenza_Adult >=65 years; Yes and health care workers, adults with chronic diseases and pregnant women and other risk groups
Influenza_Pediatric Yes children with chronic diseases
IPV 6, 14 years; Yes
MMR 1, 6 years; Yes
Td 6,14 years; Yes
TT 60 years; Yes

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2016-2018  2014-2016        2012-2014  2010-2012 
Nº of districts with microplans that include activities to raise immunization coverage number 21  21         

System performance

Total Nº districts in country number 21  21  21  113  21  113   
Nº districts with DTP3 coverage >=80% number 21  21  21  111  23  21   
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  98  110  19   
Nº districts with measles (MCV1) coverage >=95% number 11  13  13  78  16  15  17 
% of districts with MCV1 coverage >=95% From 0 to 100% 52  62  62  69  76  13   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100% 100  100  100    100   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.